Stay updated on Rucaparib+Nivolumab in Small Cell Lung Carcinoma Clinical Trial
Sign up to get notified when there's something new on the Rucaparib+Nivolumab in Small Cell Lung Carcinoma Clinical Trial page.

Latest updates to the Rucaparib+Nivolumab in Small Cell Lung Carcinoma Clinical Trial page
- Check5 days agoNo Change Detected
- Check13 days agoChange DetectedRevision: v3.3.2 is now shown, replacing v3.2.0 in the page footer. This is a minor site metadata update that does not affect study details.SummaryDifference0.1%

- Check20 days agoChange DetectedThe top funding/operational status banner was removed, while the study details remain unchanged.SummaryDifference0.4%

- Check34 days agoChange DetectedOnly minor, non-core updates to the study record are present; core details such as eligibility criteria, primary/secondary outcomes, and overall status remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check63 days agoChange DetectedAdds a government-operations notice and a v3.2.0 revision; removes the Small cell lung carcinoma resource and updates the version from v3.1.0 to v3.2.0.SummaryDifference4%

- Check70 days agoChange DetectedUpgrade applied: version updated from v3.0.2 to v3.1.0. No other substantive content changes detected.SummaryDifference0.1%

- Check84 days agoChange DetectedRevision updated to v3.0.2 (replacing v3.0.1); the Back to Top element was removed.SummaryDifference0.2%

Stay in the know with updates to Rucaparib+Nivolumab in Small Cell Lung Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Rucaparib+Nivolumab in Small Cell Lung Carcinoma Clinical Trial page.